In fact, nucleolin is overexpressed in a number of malignant tumors, including cancers of the breast, lung, stomach, pancreas, cervix, prostate as well as colorectal cancers, melanomas and leukemias [28, 47–52]. Here, NUCLEOLIN is linked to colorectal cancer.